Skip to content

EU · EudraLex Vol.4

EU GMP Annex 1 9.30

Action limits for viable particle contamination are shown in Table 6

9. Environmental & process monitoring › Environmental and personnel monitoring – viable particle

Section text

Table 6: Maximum action limits for viable particle contamination

Settle plates Contact plates Glove print, Grade Air sample (diam. 90 mm) (diam. 55mm), Including 5 fingers on CFU /m[3] CFU /4 hours(a) CFU / plate(b) both hands CFU / glove A No growth(c) B 10 5 5 5 C 100 50 25 - D 200 100 50 -

(a) - Settle plates should be exposed in grade A and B areas for the duration of operations (including equipment set-up) and changed as required after a maximum of 4 hours (exposure time should be based on validation including recovery studies and it should not have any negative effect on the suitability of the media used).

- For grade C and D areas, exposure time (with a maximum of 4 hours) and frequency should be based on QRM.

- Individual settle plates may be exposed for less than 4 hours.

(b) Contact plate limits apply to equipment, room and gown surfaces within the grade A and grade B areas. Routine gown monitoring is not normally required for grade C and D areas, depending on their function.

(c) It should be noted that for grade A, any growth should result in an investigation.

Note 1: It should be noted that the types of monitoring methods listed in the table above are examples and other methods can be used provided they meet the intent of providing information across the whole of the critical process where product may be contaminated (e.g. aseptic line set-up, aseptic processing, filling and lyophilizer loading).

Note 2: Limits are applied using CFU throughout the document. If different or new technologies are used that present results in a manner different from CFU, the manufacturer should scientifically justify the limits applied and where possible correlate them to CFU.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.